What was once a red and blue issue has now attracted a growing set of proponents from both sides of the aisle.
Bitcoin is on the rise again Thursday. Here's what you need to know.
Nickel prices have rallied to a three-year high this week.
Ultragenyx scored its second FDA drug approval in six months. The orphan disease specialist also picked up its second Rare Pediatric Disease Priority Review Voucher; its first sold for $130 million.
Aluminum prices soar to a seven-year high on Wednesday.
Two weeks ago, the agency told Alkermes it needed more trials for antidepressant drug candidate ALKS-5461. The agency, however, had a change of heart, sending shares jumping on the news.
University of Chicago professor Dennis Carlton took aim at a model that University of California Berkeley economist Carl Shapiro created for the government.
McKesson and other drug distributors are having a difficult time steering clear of controversy, with the latest blow a lawsuit alleging McKesson has violated the False Claims Act.
Just days after adding new members to its board, Deutsche Bank replaced CEO John Cryan and named Christian Sewing, who co-led the private and commercial bank, to take over.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.